FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Stryker Trevo XP ProVue Retriever Recall is Class 1

[ Price : $8.95]

FDA says the Stryker Neurovascular recall of its Trevo XP ProVue Retriever due to a core wire that may break or separate during us...

CDER Finds Ways to Streamline Schizophrenia Drug Trials

[ Price : $8.95]

CDER researchers say it may be possible to streamline clinical trials for drugs to treat schizophrenia by cutting the trial length...

Comments Extended on Animal Drug Special Programs

[ Price : $8.95]

Federal Register notice: FDA extends the comment period on a 7/15 notice about a draft guidance #61 entitled Special Consideration...

Latest FDA Warning Letter

[ Price : $8.95]

FDA releases its latest batch of Warning Letters that includes one medical product company Nartex Laboratorios Homeopaticos.

Pfizer/BioNTech Covid Vaccine 90% Effective Vaccine: Early Data

[ Price : $8.95]

Pfizer and BioNTech report data from an interim efficacy analysis showing that their Covid-19 vaccine is more than 90% effective i...

Panel Thumbs Down on Biogen Alzheimers Drug

[ Price : $8.95]

FDAs Peripheral and Central Nervous System Drugs Advisory Committee votes not to recommend approval of Biogens Alzheimers drug adu...

Former FDA Head Kessler Co-chairs Biden Covid Advisors

[ Price : $8.95]

President-elect Joe Bidens transition team announces the formation of the Transition Covid-19 Advisory Board, which is co-chaired ...

CDER Report on Clinical Trials Global Participation

[ Price : $8.95]

CDER posts a report on Global Participation in Clinical Trials: 2015-2019 that summarizes the Centers Drug Trials Snapshot program...

Guidance on Drug Compounding Insanitary Conditions

[ Price : $8.95]

Federal Register notice: FDA releases a final guidance describing insanitary conditions at drug compounding facilities.

Guide on Assessing Drug User Fees

[ Price : $8.95]

FDA posts a final guidance on Assessing User Fees Under the Prescription Drug User Fee Amendments of 2017.